| Withdrawn | Pilot Study Evaluating Tumor Microenvironment Interaction in Solid Tumor Patients NCT06922825 | Eben Rosenthal | EARLY_Phase 1 |
| Not Yet Recruiting | QLS5212 for Participants With Advanced Solid Tumors NCT07467629 | Qilu Pharmaceutical Co., Ltd. | Phase 1 |
| Recruiting | Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial NCT06802172 | Fred Hutchinson Cancer Center | N/A |
| Recruiting | Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors NCT07424547 | Conjupro Biotherapeutics, Inc. | Phase 1 |
| Recruiting | IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metas NCT07441174 | InxMed (Shanghai) Co., Ltd. | Phase 1 / Phase 2 |
| Recruiting | A First in Human Study of PLT012 in Participants With Solid Tumor Cancers NCT07337525 | Pilatus Biosciences Inc | Phase 1 |
| Recruiting | Feasibility and Acceptability of the Remote Oncology Symptom Assessment Application NCT07218874 | University of Pittsburgh | N/A |
| Not Yet Recruiting | A Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Car NCT07100925 | Ankyra Therapeutics, Inc | Phase 1 |
| Not Yet Recruiting | Safety and Efficacy of Combining a Vitamin B6-Limited Diet With Immunotherapy in Solid Tumor Patients: A Clini NCT07257497 | West China Hospital | Phase 1 |
| Not Yet Recruiting | Imaging of Solid Tumors Using DLL3 SPECT NCT07052760 | Thomas Hope | EARLY_Phase 1 |
| Recruiting | A Phase I Study of WTX212A Monotherapy or in Combination With Radiotherapy in Patients With Advanced Solid Tum NCT07269899 | Sun Yat-sen University | Phase 1 |
| Recruiting | BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or NCT07193511 | Avenzo Therapeutics, Inc. | Phase 1 / Phase 2 |
| Enrolling By Invitation | A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Product NCT06885424 | A2 Biotherapeutics Inc. | — |
| Recruiting | Preoperative Stereotactic Radiotherapy for Treatment of Spinal Metastases NCT07135817 | University Medical Center Goettingen | N/A |
| Recruiting | Exploratory Study of Super DC Cell Injection in Preventing Recurrence After Radical Surgery for Tumors NCT07146672 | Shanghai Cell Therapy Group Co.,Ltd | Phase 1 / Phase 2 |
| Not Yet Recruiting | A Multicenter, Prospective, Non-Interventional Real-World Study of Iparomlimab and Tuvonralimab Injection (QL1 NCT07046780 | PENG YUAN | — |
| Recruiting | A Study of a Distress Screening and Referral Program in People With Recently Diagnosed Cancer NCT07117461 | Memorial Sloan Kettering Cancer Center | N/A |
| Recruiting | Study of GV20-0251 in Participants With Solid Tumor Malignancies NCT07070518 | GV20 Therapeutics | Phase 1 / Phase 2 |
| Recruiting | AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced NCT07038343 | Avenzo Therapeutics, Inc. | Phase 1 / Phase 2 |
| Not Yet Recruiting | Safety and Efficacy of an Arginine-Restricted Diet in Patients With Solid Tumors NCT07038044 | West China Hospital | Phase 1 |
| Recruiting | Imatinib and Trametinib for KRAS-mutated Solid Tumor NCT06962254 | China Medical University Hospital | Phase 1 |
| Not Yet Recruiting | A Phase I, First-in-Human Study of GB268 (PD-1/CTLA-4/VEGF Trispecific Antibody) in Advanced Solid Tumors NCT06934616 | Genor Biopharma Co., Ltd. | Phase 1 |
| Recruiting | AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors NCT06911333 | Avelos Therapeutics Inc. | Phase 1 / Phase 2 |
| Recruiting | A Phase Ib/II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Patients With Advanced/Metas NCT06848699 | Shanghai Henlius Biotech | Phase 1 / Phase 2 |
| Recruiting | A Phase I Study of LXP1788 Injection with Advanced Solid Tumors. NCT06883539 | LaunXP Biomedical Co., Ltd. | Phase 1 |
| Recruiting | Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of MPD-1 in Patients With Advanced So NCT06944457 | Pharosgen Co.,Ltd | Phase 1 |
| Not Yet Recruiting | Irinotecan Liposomes Combined with Temozolomide and Vincristine in the Treatment of Pediatric Patients with So NCT06710821 | Yizhuo Zhang | Phase 1 |
| Recruiting | A Clinical Study of Personalized Self-DC Vaccine Targeting Neoantigen in Treatment of Advanced Solid Tumor NCT06682117 | Fudan University | N/A |
| Terminated | A Dose-escalation, Dose-finding, and Expansion Study of XL495 in Participants With Locally Advanced or Metasta NCT06630247 | Exelixis | Phase 1 |
| Not Yet Recruiting | A Multi-cohort Study of Efbemalenograstim Alfa Injection for Preventing ANC Reduction in Solid Tumor Patients NCT06649448 | Shandong Cancer Hospital and Institute | N/A |
| Recruiting | Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for NCT06607692 | Fundación de investigación HM | Phase 1 / Phase 2 |
| Withdrawn | A Study of Exercise Therapy in People With Solid Tumor Cancer NCT06597786 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Recruiting | Implementation of the Methylome in the Characterization of Solid Tumors NCT07268066 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Recruiting | A Single-arm Clinical Trial Using Patient-derived Tumor Tissue Fragment Models for Drug Sensitivity Testing to NCT07264803 | Qilu Hospital of Shandong University | Phase 2 |
| Completed | Study of DF6215 in Patients With Advanced Solid Tumors NCT06108479 | Dragonfly Therapeutics | Phase 1 |
| Recruiting | Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform NCT05520099 | Elephas | — |
| Recruiting | A Non-interventional, International, Multicentre Clinical Research Study to Build the Largest Collection of Mu NCT06625203 | OWKIN | — |
| Completed | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903 NCT06846099 | Risen (Suzhou) Pharma Tech Co., Ltd. | Phase 1 |
| Completed | Bioequivalence Study of Trifluridine and Tipiracil Hydrochloride Tablets on Fasting and Fed in Humans NCT07492173 | Shandong New Time Pharmaceutical Co., LTD | N/A |
| Completed | Trial of Written Exposure for Metastatic Cancer Patients (EASE) NCT06042400 | University of Colorado, Boulder | N/A |
| Recruiting | Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors NCT04354064 | Washington University School of Medicine | — |
| Unknown | A Retrospective Immunohistochemistry Study of the Expression of Glycine/ Serine Pathway Molecules in Solid Tum NCT02103920 | National University Hospital, Singapore | — |
| Withdrawn | A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic NCT00891761 | GlaxoSmithKline | Phase 3 |
| Completed | Ispinesib In Combination With Capecitabine In Patients With Solid Tumors NCT00119171 | GlaxoSmithKline | Phase 1 |
| Completed | SB-715992 In Combination With Docetaxel In Patients With Solid Tumors NCT00169520 | GlaxoSmithKline | Phase 1 |
| Completed | SB-743921 In Patients With Solid Tumors NCT00136513 | GlaxoSmithKline | Phase 1 |
| Completed | Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or Lym NCT00085904 | GlaxoSmithKline | Phase 1 |
| Completed | Dose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid Tumors NCT00085878 | GlaxoSmithKline | Phase 1 |
| Completed | A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors NCT00046111 | GlaxoSmithKline | Phase 1 |
| Available | MNPR-101-PCTA-177Lu Expanded Access Program (EAP) for Patients With Solid Tumor Cancer NCT06980519 | Monopar Therapeutics | — |